These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6117088)

  • 21. Serum growth hormone response to bromocriptine during a glucose tolerance test in acromegaly.
    Cassar J; Mashiter K; Sullivan G; Joplin GF
    Acta Endocrinol (Copenh); 1976 May; 82(1):39-46. PubMed ID: 946714
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of thyrotrophin releasing hormone on the release of thyrotrophin and other pituitary hormones in man under basal conditions and following adrenergic blocking agents.
    Nilsson KO; Thorell JI; Hökfelt B
    Acta Endocrinol (Copenh); 1974 May; 76(1):24-34. PubMed ID: 4208441
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of various adrenergic receptor stimulating and blocking agents on human growth hormone secretion.
    Massara F; Camanni F
    J Endocrinol; 1972 Aug; 54(2):195-206. PubMed ID: 4403626
    [No Abstract]   [Full Text] [Related]  

  • 24. [Somatotrophic response to hypoglycemic stimulus in patients with acromegaly. Effect of bromocriptine].
    Fiszlejder L; Bokser L; Puyo AM; Chervin AB; Guitelman A
    Medicina (B Aires); 1986; 46(1):16-24. PubMed ID: 3543606
    [No Abstract]   [Full Text] [Related]  

  • 25. Influence of adrenergic receptor stimulation on glucose metabolism during starvation in man: effects on circulating levels of insulin growth hormone and free fatty acids.
    Misbin RI; Edgar PJ; Lockwood DH
    Metabolism; 1971 Jun; 20(6):544-54. PubMed ID: 4325409
    [No Abstract]   [Full Text] [Related]  

  • 26. Experimental modification of the sleep-induced peak of growth hormone secretion.
    Lucke C; Glick SM
    J Clin Endocrinol Metab; 1971 Jun; 32(6):729-36. PubMed ID: 4397015
    [No Abstract]   [Full Text] [Related]  

  • 27. Proof for histaminergic but not for adrenergic involvement in the growth hormone-releasing effect of an enkephalin analog in the dog.
    Casanueva F; Betti R; Cocchi D; Chieli T; Mantegazza P; Müller EE
    Endocrinology; 1981 Jan; 108(1):157-63. PubMed ID: 7460816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of TRF, propranolol-glucagon, insulin and glucose stimulation tests in acromegaly.
    Coutant G; Vandeweghe M; Vermeulen A
    Horm Metab Res; 1977 Jan; 9(1):17-21. PubMed ID: 403115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of propranolol and phentolamine on the hypoglycemic action of vasopressin in the dog].
    Baisset A; Dang-Tran L; Montastruc P
    Therapie; 1972; 27(3):510-6. PubMed ID: 4655216
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of growth hormone, glucose and insulin on the factor VIII complex.
    Lowe GD; Middleton SM; Hay ID; Beastall GH; Singaraveloo M; Cohen HN; Thomson JA; Forbes CD; Prentice CR
    Thromb Res; 1982 Oct; 28(2):201-11. PubMed ID: 6817455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alpha-adrenergic regulation of growth hormone release after electroconvulsive therapy in man.
    Vigas M; Wiedermann V; Németh S; Jurcovicová J; Zigo L
    Neuroendocrinology; 1976; 21(1):42-8. PubMed ID: 794753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of adrenergic receptor blockade on the exercise-induced serum growth hormone rise in normals and juvenile diabetics.
    Hansen AP
    J Clin Endocrinol Metab; 1971 Nov; 33(5):807-12. PubMed ID: 4399438
    [No Abstract]   [Full Text] [Related]  

  • 33. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
    Hanew K; Sasaki A; Sato S; Goh M; Yoshinaga K
    J Clin Endocrinol Metab; 1987 Feb; 64(2):255-60. PubMed ID: 3793848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of adrenergic receptor blockade on cortisol and GH response to insulin-induced hypoglycemia in man.
    Jezová-Repceková D; Klimes I; Jurcovicová J; Vigas M
    Int J Clin Pharmacol Biopharm; 1979 Feb; 17(2):64-7. PubMed ID: 422303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of bromocriptine on maturity onset diabetes.
    Barnett AH; Chapman C; Gailer K; Hayter CJ
    Postgrad Med J; 1980 Jan; 56(651):11-4. PubMed ID: 6992131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of sulfpride and ergot derivatives on rat brain DOPAC concentration and prolactin secretion in vivo.
    Hofmann M; Battaini F; Tonon G; Trabucchi M; Spano P
    Eur J Pharmacol; 1979 Jun; 56(1-2):15-20. PubMed ID: 467503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acidosis-induced glucose intolerance is not prevented by adrenergic blockade.
    Adrogué HJ; Chap Z; Okuda Y; Michael L; Hartley C; Entman M; Field JB
    Am J Physiol; 1988 Dec; 255(6 Pt 1):E812-23. PubMed ID: 3144181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Secretion of human growth hormone (HGH). 2. Effects of adrenergic stimulating or blocking drugs on serum HGH].
    Kato Y
    Nihon Naibunpi Gakkai Zasshi; 1972 Aug; 48(5):352-63. PubMed ID: 4404067
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of dopamine and bromocriptine on colonic motility in dog.
    Bueno L; Fargeas MJ; Fioramonti J; Honde C
    Br J Pharmacol; 1984 May; 82(1):35-42. PubMed ID: 6145468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paradoxical release of growth hormone during oral glucose tolerance test in patients with abnormal glucose tolerance.
    Grecu EO; Walter RM; Gold EM
    Metabolism; 1983 Feb; 32(2):134-7. PubMed ID: 6338346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.